BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2008
View Archived Issues
Wetimicin studied in phase I in China as new broad-spectrum antibiotic
Read More
New preclinical data demonstrate antidepressant activity of ITI-007
Read More
Aradigm initiates clinical trial of Lung Rx's inhaled treprostinil using AERx Essence
Read More
Schering-Plough terminates collaboration agreement with Novacea for Asentar
Read More
CuraGen advances CR011-vcMMAE into phase II for advanced melanoma
Read More
Futura Medical updates progress on development of TPR-100 using DermaSys
Read More
Glucose-lowering activity of Merck's novel glucagon receptor antagonist shown in vivo
Read More
Pfizer's novel 5-HT1B inverse agonist shows antidepressant activity in vivo
Read More
In vivo cognitive enhancement by WAY-101, a novel 5-HT6 antagonist
Read More
Novel agents for cardiovascular disorders disclosed in recent patent
Read More
New wound-healing agents described in recent Hokkaido University and Shionogi patent
Read More
New immunosuppressants reported in recent patent literature
Read More
ImClone Systems initiates phase II clinical trial of IMC-A12 in head and neck cancer
Read More
Lorus signs exclusive multinational license agreement with Zoticon for Virulizin
Read More
FDA grants orphan drug designation to Kamada's aerosolized AAT for bronchiectasis
Read More
Immunomedics reports results from phase I/II study of veltuzumab
Read More
Barrier Therapeutics reports positive results from phase II study of oral antihistamine Hivenyl
Read More
FDA grants fast track designation to Neopharm's NPL-2008 in autism disorder
Read More
Recombinant butyrylcholinesterase may play a neuroprotective role in AD
Read More
FDA accepts oritavancin NDA for standard review
Read More
Potentia completes round of financing to advance POT-4 clinical program in AMD
Read More
Abilify granted EU marketing authorization for manic episodes in bipolar I
Read More
Amrubicin designated EMEA orphan medicinal product for small cell lung cancer
Read More
Alimta approved for histologically based use in non-small cell lung cancer
Read More
Sustained release of platinum species seen with NC-6004 in cancer patients
Read More
Clinical responses seen with AME-133v in phase I/II study
Read More